Once-yearly therapy is enough to stave off glucocorticoid-induced bone loss

被引:0
|
作者
Negin Nassabeh
机构
关键词
D O I
10.1038/nrrheum.2009.101
中图分类号
学科分类号
摘要
引用
收藏
页码:293 / 293
相关论文
共 50 条
  • [2] Bone histomorphometry analyses in glucocorticoid-induced osteoporosis patients treated with once-yearly zoledronic acid or oral risedronate over 1 year
    Recker, R.
    Reid, D.
    Papanastasiou, P.
    Chappard, D.
    BONE, 2011, 48 : S205 - S205
  • [3] The science and therapy of glucocorticoid-induced bone loss
    Lane, NE
    Lukert, B
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1998, 27 (02) : 465 - +
  • [4] Glucocorticoid-induced bone loss in children
    Gordon L. Klein
    Clinical Reviews in Bone and Mineral Metabolism, 2004, 2 (1): : 37 - 52
  • [5] ESTROGEN AND PROGESTERONE REPLACEMENT THERAPY REDUCES GLUCOCORTICOID-INDUCED BONE LOSS
    LUKERT, BP
    JOHNSON, BE
    ROBINSON, RG
    JOURNAL OF BONE AND MINERAL RESEARCH, 1992, 7 (09) : 1063 - 1069
  • [6] Effect of alendronate once weekly on bone mineral density in patients with glucocorticoid-induced bone loss.
    Stoch, S. A.
    Verbruggen, N.
    Giezek, H.
    Maragoto, A.
    Saag, K.
    Schnitzer, T.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S418 - S419
  • [7] GLUCOCORTICOID-INDUCED BONE LOSS - A NEGLECTED PROBLEM
    LUKERT, BP
    CHEST, 1994, 105 (06) : 1640 - 1641
  • [8] DOES ONCE-YEARLY ZOLEDRONATE ABATE BONE PAIN IN POSTMENOPAUSAL OSTEOPOROSIS
    Nestorova, R.
    Marinchev, L.
    Rashkov, R.
    Kolarov, Z.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 351 - 351
  • [9] Cell Transitions Contribute to Glucocorticoid-Induced Bone Loss
    Qiao, Xiaojing
    Wu, Xiuju
    Zhao, Yan
    Yang, Yang
    Zhang, Li
    Cai, Xinjiang
    Ma, Jocelyn A. A.
    Ji, Jaden
    Lyons, Karen
    Bostrom, Kristina I. I.
    Yao, Yucheng
    CELLS, 2023, 12 (14)
  • [10] Glucocorticoid-induced bone loss in dermatologic patients - An update
    Summey, BT
    Yosipovitch, G
    ARCHIVES OF DERMATOLOGY, 2006, 142 (01) : 82 - 90